Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.6419
+0.0522 ( -20.51% ) 150.7M
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.6419
Previous close
$0.5897
Volume
150.7M
Market cap
$4.77M
Day range
$0.6210 - $1.1580
52 week range
$0.3625 - $5.5070
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Nov 22, 2024 |
| 8-k | 8K-related | 14 | Nov 20, 2024 |
| pre | Proxies and info statements | 4 | Nov 20, 2024 |
| 8-k | 8K-related | 20 | Nov 15, 2024 |
| 10-q | Quarterly Reports | 59 | Nov 14, 2024 |
| 10-k/a | Quarterly Reports | 16 | Oct 10, 2024 |
| 10-k/a | Quarterly Reports | 16 | Oct 10, 2024 |
| 8-k/a | 8K-related | 15 | Oct 09, 2024 |
| 8-k | 8K-related | 13 | Oct 07, 2024 |
| 8-k | 8K-related | 13 | Oct 04, 2024 |